Sharon Benzeno Adaptive Biotechnologies Corp (ADPT) insider trading activity

Sharon Benzeno is Chief Commercial Ofc Imm Med of Adaptive Biotechnologies Corp. Currently has a direct ownership of 327,415 shares of ADPT, which is worth approximately $1.88 Million. The most recent transaction as insider was on Nov 19, 2020, when has been sold 416 shares (Common Stock) at a price of $48.86 per share, resulting in proceeds of $20,326. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 327K

0% 3M change

46.28% 12M change

Total Value Held $1.88 Million

SHARON BENZENO Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 19 2020	SELL Open market or private sale	$20,326 $48.86 p/Share	416 Reduced 100.0%	0 Common Stock
Nov 19 2020	BUY Exercise of conversion of derivative security	$2,608 $6.27 p/Share	416 Added 50.0%	416 Common Stock
Nov 02 2020	SELL Open market or private sale	$310,225 $45.81 p/Share	6,772 Reduced 100.0%	0 Common Stock
Nov 02 2020	BUY Exercise of conversion of derivative security	$45,982 $6.79 p/Share	6,772 Added 50.0%	6,772 Common Stock
Oct 19 2020	SELL Open market or private sale	$21,371 $51.25 p/Share	417 Reduced 100.0%	0 Common Stock
Oct 19 2020	BUY Exercise of conversion of derivative security	$2,615 $6.27 p/Share	417 Added 50.0%	417 Common Stock
Oct 01 2020	SELL Open market or private sale	$330,831 $48.86 p/Share	6,771 Reduced 100.0%	0 Common Stock
Oct 01 2020	BUY Exercise of conversion of derivative security	$45,975 $6.79 p/Share	6,771 Added 50.0%	6,771 Common Stock

Sharon Benzeno

Chief Commercial Ofc Imm Med

Seattle, WA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADPT shares.

Notify only if

Value

Insider Trading

Get notified when an Adaptive Biotechnologies Corp insider buys or sells ADPT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Adaptive Biotechnologies Corp

Track Activities on ADPT

Account